No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Melissa R. Warden, Ph.D., of Stanford University, expert on schizophrenia
Melissa R. Warden, Ph.D.
June 10, 2013
A team of neuroscientists, including NARSAD Young Investigator Grantee Melissa R. Warden, Ph.D., of Stanford University, devised new analytical methods to...
Dorit Ben-Shachar, Ph.D., D.Sc., of Technion Israel Institute of Technology (TIIT), expert on schizophrenia research
Dorit Ben-Shachar, Ph.D., D.Sc.
June 07, 2013
Brain & Behavior Research Foundation NARSAD Grantee Dorit Ben-Shachar, D.Sc., of the Rambam Health Care Campus and the Technion Israel Institute of...
Kirsty Spalding, Ph.D., expert on brain research and brain plasticity
Kirsty Spalding, Ph.D.
June 06, 2013
In 2013, NARSAD Grantee Kirsty Spalding, Ph.D., and team at the Karolinska Institutet in Stockholm, Sweden, used an innovative methodology to identify the “...
Nancy Andreasen, M.D., Ph.D., University of Iowa, Expert on Schizophrenia
Nancy Andreasen, M.D., Ph.D.
June 06, 2013
Substantial evidence suggests that patients with schizophrenia have, on average, smaller volumes in several brain areas such as the frontal lobes, and that...
Olivier J. Manzoni, Ph.D., of INSERM, expert on post-traumatic stress disorder (PTSD) and anxiety disorders
Olivier J. Manzoni, Ph.D.
June 04, 2013
Researchers commonly use fear extinction as the main line of treatment for anxiety disorders. Extinction therapy aims to train the patient to distinguish non-...

Pages

Subscribe to